Starting a Cannabis Business in Ireland

Licensing
Required
Foreign Ownership
Allowed
Timeline
3-6 months for CBD retail
Business Types
3
Medical Cannabis Access ProgramCBD RetailHemp Cultivation

Market Overview

Ireland's cannabis market is in its early stages, with limited medical access through the Medical Cannabis Access Programme (MCAP) and a growing but cautious CBD retail sector. MCAP, established in 2019, provides access to cannabis-based treatments for three specific conditions: spasticity associated with multiple sclerosis, intractable nausea and vomiting from chemotherapy, and severe treatment-resistant epilepsy. Patient numbers under the program remain small, reflecting both the restrictive qualifying criteria and the challenges of navigating the access process. The CBD retail market has grown alongside broader European trends, with products available in health food shops, pharmacies, and online. However, the FSAI and EU Novel Food requirements create compliance costs that challenge smaller operators. Ireland's English-speaking environment, common law legal system, and EU membership make it attractive for UK-based companies seeking to maintain EU market access. Hemp cultivation is permitted under HPRA licensing but remains a niche activity. For entrepreneurs, Ireland offers modest near-term opportunities with potential for growth if the MCAP is expanded or broader legislative reform occurs.

Capital Requirements

Moderate; medical cannabis supply requires pharmaceutical infrastructure, CBD retail is relatively accessible

Application Process

1

Register an Irish legal entity (Ltd or DAC) with the Companies Registration Office (CRO) and obtain necessary business permits.

2

For CBD retail, ensure products comply with Food Safety Authority of Ireland (FSAI) regulations and EU Novel Food requirements, with THC content below the permitted threshold.

3

For participation in the Medical Cannabis Access Programme (MCAP), apply to the Health Products Regulatory Authority (HPRA) as an authorized supplier of cannabis-based products.

4

For hemp cultivation, obtain a license from the Health Products Regulatory Authority (HPRA) for cultivation of EU-certified hemp varieties with less than 0.2% THC.

5

Maintain comprehensive quality documentation, product traceability, and compliance with all HPRA and FSAI reporting requirements.

Estimated timeline: 3-6 months for CBD retail; 6-12 months for MCAP supplier authorization

Key Regulations

  • •The Medical Cannabis Access Programme (MCAP) was established in 2019 allowing access to cannabis-based products for specific conditions not responding to conventional treatment.
  • •MCAP covers three conditions: spasticity from MS, intractable nausea from chemotherapy, and severe treatment-resistant epilepsy.
  • •CBD products are legal as food supplements if they comply with FSAI and EU Novel Food regulations.
  • •Hemp cultivation requires an HPRA license, and Ireland's hemp industry is relatively small but growing.

Opportunities

+

English-speaking EU market with common law legal framework, attractive for UK and US companies seeking EU access.

+

Growing CBD consumer market with increasing mainstream retail availability.

+

MCAP expansion could open new patient categories and increase demand for authorized suppliers.

+

Strong pharmaceutical industry presence (major pharma hub) providing infrastructure and talent for cannabis businesses.

Challenges

!

Very restrictive MCAP with only three qualifying conditions and low patient enrollment.

!

Conservative political environment with limited appetite for cannabis liberalization.

!

Small market size (5.1 million population) limiting domestic revenue potential.

!

EU Novel Food compliance costs and FSAI requirements create barriers for CBD market entry.

Frequently Asked Questions

How does the Irish Medical Cannabis Access Programme work?

MCAP allows consultants (not GPs) to prescribe cannabis-based products for three conditions: MS-related spasticity, chemotherapy-induced nausea, and severe epilepsy. Products must be prescribed by a hospital consultant and sourced from HPRA-authorized suppliers. The program is intended as a pathway of last resort when conventional treatments have failed.

Can I sell CBD oil in Ireland?

Yes, CBD products can be sold in Ireland as food supplements if they comply with FSAI regulations, EU Novel Food requirements, and contain THC below the permitted threshold. Products must not make medicinal claims and must meet labeling and safety requirements.

Is recreational cannabis likely to be legalized in Ireland?

As of 2025, recreational cannabis legalization is not imminent in Ireland. A Citizens' Assembly on Drug Use was convened and made recommendations, but legislative action has been slow. The political environment is cautious, and any changes would likely be incremental rather than comprehensive legalization.

Related Country Guides

Starting a Cannabis Business in United Kingdom

Starting a cannabis business in the UK. Guide to medical cannabis clinics, CBD brand regulations, FSA Novel Food authorization, and CBPM licensing requirements.

Starting a Cannabis Business in Netherlands

How to start a cannabis coffeeshop or CBD business in the Netherlands. Licensing requirements, the back-door problem, Wietexperiment, and AHOJGI compliance guide.

Starting a Cannabis Business in Germany

Guide to starting a cannabis business in Germany. Learn about cannabis social clubs, medical distribution licenses, cultivation permits, and the CanG regulatory framework.

Explore More

All European Markets|Europe Overview|Legalization Tracker|Industry Analysis

Disclaimer: This information is for educational purposes only and does not constitute legal, financial, or business advice. Cannabis regulations in Ireland are subject to change. Consult with qualified legal and financial professionals familiar with Ireland's regulatory framework before starting any cannabis-related business. Cannabismarketcap does not guarantee the accuracy or completeness of any information presented.